CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...